Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03912298 · ClinicalTrials.gov registry record
Opioid Taper Study
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 7
- Enrollment target
NCT03912298: Completed study, sponsored by University of Pennsylvania.
NCT03912298 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03912298 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of opioid taper on pain sensitivity in patients with chronic pain. In a well-characterized sample of men and women with chronic neuropathic pain on high-dose opioid therapy, experimental pain responses (cold-pressor, quantitative sensory testing) will be serially described over the course of and following an individualized opioid taper. In addition, functional improvements and subject-level predictors of response will be described.
Interventions
- OTHER Opioid Taper Pain perception
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2021-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03912298
The ClinicalTrials.gov registry entry for NCT03912298 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Opioid Taper Pain perception is the first listed.
NCT03912298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03912298 about?
NCT03912298 is a clinical study titled "Opioid Taper Study". The purpose of this study is to determine the effect of opioid taper on pain sensitivity in patients with chronic pain. In a well-characterized sample of men and women with chronic neuropathic pain on high-dose opioid therapy, experimental pain responses (cold-pressor, quantitative sensory testing) ...
What is the current status of trial NCT03912298?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2019-04-15. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT03912298?
The interventions under investigation include: Opioid Taper Pain perception (OTHER).
Who is sponsoring clinical trial NCT03912298?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.